With the aim of discovering novel small molecules for the treatment of HAFOUS, Maisonet and coworkers carried out a large-scale screening and identified the compound MS-8 (Figure 16) as a potential USP7 activator. The gene discussed is USP7; the disease is Hao-Fountain syndrome.